New Uses for Blood Pressure Drug Approved
Posted on: Thursday, 4 August 2005, 18:01 CDT
THURSDAY, Aug. 4 (HealthDay News) -- The U.S. Food and Drug Administration has approved expanded use of the blood pressure medication Diovan (valsartan) to include improving certain patients' chances of surviving a heart attack, manufacturer Novartis Pharmaceuticals said Thursday.
The new indication applies only to high-risk heart attack survivors who have a condition called left ventricular dysfunction, the company said.
The FDA also broadened the drug's labeling to allow doctors to prescribe it to a wider range of heart-failure patients, Novartis said. Up to now, the drug had been officially limited to heart-failure patients who were intolerant to a class of medicines called ACE inhibitors.
The company warned that Diovan should be discontinued as soon as a woman learns she is pregnant because the drug could cause serious harm, even death, to a fetus.
To learn more about Diovan, visit the National Library of Medicine.
~RXOK~~HRTS~~HIBP~~FDA-~
Source: HealthSCOUT
Related Articles
- Many Heart Failure Patients Do Not Get Proper Drug Treatments
- Heart Transplant Patient Returns After Scaling Antarctic Mountain
- Heart Transplant Patient Reports Significant Results With Medication and Treatment Compliance Using the ALRT500 Home Health Management System
- FDA OKs drug for heart transplant patients
- Vanderbilt Enrolling Heart Failure Patients in New Pacing Device Study
- Medications Keep Heart-Failure Patients Alive
- Data From Two Published Studies Show Short- and Long- Term Benefits of CHF Solutions' Aquapheresis(TM) Therapy in Treating Heart Failure Patients With Fluid Overload
- Role of Cholesterol Lowering Drugs in Heart Failure Patients Evaluated in Yale Medical Center's Heart Study
- Lowering BP With Medication Provides Unexpected Benefits for Heart Disease Patients With 'Normal' Blood Pressure
- Drug May Help Heart Transplant Patients
 |
 |
User Comments (0)
RSS Feeds